Obstructive sleep apnea (OSA) is a common respiratory condition characterized by respiratory tract obstruction and breathing disorder. Early detection and treatment of OSA can significantly reduce morbidity and mortality. OSA is often diagnosed with overnight polysomnography (PSG) monitoring; however, continuous PSG monitoring is unfeasible as it is costly and uncomfortable for patients. To circumvent these issues, we propose a detection method of OSA events, named DRIVEN, using only two signals that can be easily measured at home: abdominal movement and pulse oximetry. On test data, DRIVEN achieves an accuracy and F1-score of 88%, a reasonable trade-off between the model ‘s performance and patient ‘s comfort. We use data from three sleep studies from the National Sleep Research Resource (NSRR), the largest public repository, consisting of 10,878 recordings. DRIVEN is based on a combination of deep convolutional neural networks and a light-gradient-boost machine for classification. Since DRIVEN is simple and computationally efficient, we expect that it can be implemented for automatic detection of OSA in unsupervised long-term home monitoring systems, reducing costs to healthcare systems and improving patient care.

The authors have declared no competing interest.

Luxembourg National Research Fund (FNR) through PRIDE15/10907093/CriTiCS.

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study used ONLY openly available human data that were originally located at: https://sleepdata.org/

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes